Blood inflammation marker flags severity in vomiting dogs, but sky-high readings don’t spell doom

When a dog starts vomiting, one of the first questions a veterinarian faces is whether the episode is a passing upset or the first sign of something serious. A retrospective study from South Korea offers fresh insight into that dilemma by examining C-reactive protein, or CRP, a major blood marker of systemic inflammation, in nearly 500 dogs brought to a primary care hospital with acute vomiting. The findings, published in Frontiers in Veterinary Science, show that higher initial CRP concentrations track with sicker-looking patients and a higher risk of death within two weeks, yet they also carry a reassuring caveat: most dogs with the most extreme CRP values survived.

The research team, led by veterinarians affiliated with Chonnam National University and primary care hospitals in Gwangju and Busan, reviewed the medical records of 481 client-owned dogs that presented with vomiting of less than two weeks’ duration between September 2021 and November 2024. To be included, each dog had to have a CRP measurement taken at the very first visit, before any therapeutic intervention began. Dogs treated for gastrointestinal disease in the previous three months, or those lacking follow-up information, were excluded. From an initial pool of 943 vomiting dogs, 462 were removed because no diagnostic testing was performed, follow-up information was unavailable, or testing occurred without CRP measurement. The remaining cohort was overwhelmingly small in stature: the median body weight was just 4.5 kilograms, the median age 4.5 years, and Miniature Poodles, Pomeranians, Maltese, and Bichon Frises dominated the breed list, reflecting the regional companion dog population.

CRP is a major acute-phase protein in dogs, surging in the bloodstream when inflammation is triggered anywhere in the body. It is highly sensitive but entirely non-specific, rising in infections, pancreatitis, cancer, and many other inflammatory conditions. Although previous canine studies have explored CRP as a prognostic marker in diseases such as parvovirus infection, pancreatitis, and acute abdomen, its utility in dogs with acute vomiting presenting to primary care practices had remained poorly defined. Previous canine studies have also used concentrations above 35 milligrams per liter to define systemic inflammation, while the point-of-care analyzer used in this study, the VetChroma device, considers anything below 10 milligrams per liter to be within the manufacturer’s reference interval, with an analytical measurement range of 5 to 500 milligrams per liter. The researchers therefore sorted their patients into three mutually exclusive groups: Group A with CRP below 10 milligrams per liter, Group B between 10 and 35, and Group C at or above 35 milligrams per liter.

The median CRP concentration across the whole cohort was 14 milligrams per liter, with an interquartile range of 6 to 57. The 481 dogs split into 204 in Group A, 119 in Group B, and 158 in Group C. When the team compared clinical presentations, a clear gradient emerged. Dogs in the highest CRP group vomited more often, with 51.9 percent vomiting three to seven times a day and 24.7 percent vomiting eight or more times daily, compared with far lower frequencies in the other groups. Reduced appetite was reported in 77.8 percent of Group C dogs versus roughly half of the other groups, and reduced activity in 72.2 percent versus 29.9 to 38.7 percent. All of these differences were statistically significant, with Holm-adjusted pairwise comparisons confirming that Group C stood apart from both lower groups, which did not differ from each other.

Interestingly, not every gastrointestinal sign followed the CRP gradient. The prevalences of diarrhea, hematemesis, or vomiting of blood, and hematochezia, or blood in the stool, were statistically similar across the three groups. This suggests, the authors argue, that CRP reflects the overall intensity of the systemic inflammatory response and the dog’s general clinical status rather than any single digestive symptom. It aligns with earlier work in canine inflammatory bowel disease, where CRP tracked clinical disease activity, and with severity assessments for gastrointestinal disorders that incorporate attitude, appetite, and vomiting frequency.

Diagnosis proved to be the study’s stubborn challenge. Beyond the CRP measurement, the dogs underwent a patchwork of additional tests: abdominal radiography in 67.8 percent of cases, the canine pancreas-specific lipase test in 60.1 percent, complete blood counts in 51.6 percent, abdominal ultrasonography in 46.8 percent, blood chemistry analysis in 34.5 percent, and rectal scrapings or ACTH stimulation tests in smaller numbers. Despite this, a definitive underlying cause was established in only 117 of the 481 dogs, or 24.3 percent. Pancreatitis led the list at 45 cases, followed by gastric foreign bodies at 21 and small intestinal foreign bodies at 12. Rarer culprits included pyometra, abdominal masses, kidney disease, intoxication, acute hemorrhagic diarrhea syndrome, coronavirus and parvovirus infections, and immune-mediated diseases. Median CRP concentrations were descriptively highest in conditions such as pyometra at 106.2 milligrams per liter, acute hemorrhagic diarrhea syndrome at 87, and pancreatitis at 51, but the overlap across diagnoses was substantial, and even dogs with no definitive diagnosis spanned the full range. A single CRP value, the authors conclude, is far better suited as an adjunctive marker of systemic inflammation than as a tool for pinpointing the cause of vomiting.

Treatment in the cohort mostly consisted of standard supportive medical management, most commonly gastroprotectants and antiemetics, with specific interventions reserved for identified causes. Six dogs with gastric foreign bodies underwent endoscopic or surgical removal, nine of twelve dogs with small intestinal foreign bodies had surgery, all six dogs with pyometra underwent ovariohysterectomy, and three dogs with abdominal masses had the masses removed, yielding diagnoses of splenic hemangiosarcoma or an abdominal mast cell tumor.

The outcome data sharpened the picture. Seventeen dogs died within 14 days of presentation, and mortality differed significantly among the CRP groups. In Group C, 13 of 158 dogs died, an 8.2 percent mortality rate, compared with 1.0 percent in Group A and 1.7 percent in Group B. Non-surviving dogs had a median CRP of 77 milligrams per liter, significantly higher than the 13 milligrams per liter seen in survivors. Kidney disease was the most common primary condition among the dogs that died, followed by pancreatitis and abdominal masses. The authors caution, however, that the concentration of deaths among kidney-disease patients may partly reflect the limited access to advanced supportive or referral-level interventions in a primary care setting, and that owner-related factors such as financial constraints may have influenced decisions about intensive treatment, referral, or euthanasia.

The most striking and clinically reassuring result concerned the dogs with the most extreme inflammation. Forty-four dogs, 9.1 percent of the cohort, had CRP concentrations above 100 milligrams per liter, yet only two of them, or 4.5 percent, died within 14 days. Among the 22 dogs in this high-CRP subgroup without a definitive diagnosis, every single one survived the follow-up period. The authors contrast this with an earlier referral-hospital study that reported a 37 percent three-month mortality rate among dogs with CRP above 100 milligrams per liter, while noting that the two figures are not directly comparable because of differences in patient selection, disease distribution, and follow-up duration. Their message is nonetheless clear: a markedly elevated CRP value alone should not be equated with a grave short-term prognosis in an individual vomiting dog.

Timing adds another layer of nuance. Because CRP does not rise immediately after an inflammatory stimulus but increases over time as the systemic acute-phase response develops, a dog examined very early in the course of an acute inflammatory illness such as pancreatitis may show a normal or only mildly elevated value despite significant disease. The authors therefore warn against interpreting a low or modest CRP reading as proof of mild disease, particularly early in the clinical course, and note that serial measurements may be more informative in selected patients, although dynamic CRP trends were not systematically evaluated in this study. The study’s limitations deserve equal emphasis. Its retrospective design meant diagnostic work-ups were not standardized, so some diseases may have gone undetected and contributed to the diagnostic overlap. Requiring a CRP test at presentation introduces potential selection bias, since dogs chosen for testing may have differed in perceived severity from those managed without it. The cohort was single-center and dominated by small breeds, which may limit generalizability to populations with more large-breed dogs, and with only 17 deaths, the statistical power was too low for robust multivariable analysis of mortality risk factors. The authors are careful to state that these constraints preclude any claim that CRP is independently associated with mortality and do not permit causal inference about the relationship between CRP and outcome. What the study does establish, at the level of this primary care cohort, is an association: higher initial CRP concentrations went hand in hand with more frequent vomiting, reduced appetite, reduced activity, and increased 14-day all-cause mortality. For practicing veterinarians, the takeaway is to read CRP alongside the history, physical examination, and other diagnostic findings, treating it as one piece of the clinical puzzle rather than a verdict on an individual dog’s fate.

Subject of Research: C-reactive protein concentrations in dogs with acute vomiting in primary care and their association with clinical presentation and short-term mortality

Article Title: C-reactive protein concentrations, clinical presentation, and short-term outcome in dogs with acute vomiting: a retrospective primary care cohort

Article References: Park, S.-W., Baek, S.-H., Oh, M.-K., Do, Y.-J., Ro, W.-B., & Lee, C.-M. (2026). C-reactive protein concentrations, clinical presentation, and short-term outcome in dogs with acute vomiting: a retrospective primary care cohort. Frontiers in Veterinary Science, 13, Article 1990737. https://doi.org/10.3389/fvets.2026.1990737

Image Credits: AI Generated

DOI: 10.3389/fvets.2026.1990737

Keywords: C-reactive protein, dogs, acute vomiting, veterinary medicine, inflammation, prognosis, primary care, retrospective cohort, pancreatitis, acute-phase protein, mortality, canine health